A gender-based secondary analysis of the ADAPT-2 combination naltrexone and bupropion treatment for methamphetamine use disorder trial.
Saved in:
| Title: | A gender-based secondary analysis of the ADAPT-2 combination naltrexone and bupropion treatment for methamphetamine use disorder trial. |
|---|---|
| Authors: | Levander XA; Oregon Health and Science University, Department of Medicine, Division of General Internal Medicine and Geriatrics, Addiction Medicine Section, Portland, OR, USA., Carmody T; Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA., Cook RR; Oregon Health and Science University, Department of Medicine, Division of General Internal Medicine and Geriatrics, Addiction Medicine Section, Portland, OR, USA., Potter JS; Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center San Antonio, San Antonio, TX, USA., Trivedi MH; Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA., Korthuis PT; Oregon Health and Science University, Department of Medicine, Division of General Internal Medicine and Geriatrics, Addiction Medicine Section, Portland, OR, USA., Shoptaw S; Department of Family Medicine, University of California Los Angeles, Los Angeles, CA, USA.; Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, CA, USA. |
| Source: | Addiction (Abingdon, England) [Addiction] 2023 Jul; Vol. 118 (7), pp. 1320-1328. Date of Electronic Publication: 2023 Mar 02. |
| Publication Type: | Randomized Controlled Trial; Multicenter Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S. |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9304118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1360-0443 (Electronic) Linking ISSN: 09652140 NLM ISO Abbreviation: Addiction Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36864016 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A gender-based secondary analysis of the ADAPT-2 combination naltrexone and bupropion treatment for methamphetamine use disorder trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Levander+XA%22">Levander XA</searchLink>; Oregon Health and Science University, Department of Medicine, Division of General Internal Medicine and Geriatrics, Addiction Medicine Section, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Carmody+T%22">Carmody T</searchLink>; Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA.<br /><searchLink fieldCode="AU" term="%22Cook+RR%22">Cook RR</searchLink>; Oregon Health and Science University, Department of Medicine, Division of General Internal Medicine and Geriatrics, Addiction Medicine Section, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Potter+JS%22">Potter JS</searchLink>; Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center San Antonio, San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Trivedi+MH%22">Trivedi MH</searchLink>; Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA.<br /><searchLink fieldCode="AU" term="%22Korthuis+PT%22">Korthuis PT</searchLink>; Oregon Health and Science University, Department of Medicine, Division of General Internal Medicine and Geriatrics, Addiction Medicine Section, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Shoptaw+S%22">Shoptaw S</searchLink>; Department of Family Medicine, University of California Los Angeles, Los Angeles, CA, USA.; Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, CA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229304118%22">Addiction (Abingdon, England)</searchLink> [Addiction] 2023 Jul; Vol. 118 (7), pp. 1320-1328. <i>Date of Electronic Publication: </i>2023 Mar 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Randomized Controlled Trial; Multicenter Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S. – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9304118 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1360-0443 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209652140%22">09652140 </searchLink><i>NLM ISO Abbreviation: </i>Addiction <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36864016 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/add.16163 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1320 Titles: – TitleFull: A gender-based secondary analysis of the ADAPT-2 combination naltrexone and bupropion treatment for methamphetamine use disorder trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Levander XA – PersonEntity: Name: NameFull: Carmody T – PersonEntity: Name: NameFull: Cook RR – PersonEntity: Name: NameFull: Potter JS – PersonEntity: Name: NameFull: Trivedi MH – PersonEntity: Name: NameFull: Korthuis PT – PersonEntity: Name: NameFull: Shoptaw S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2023 Jul Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1360-0443 Numbering: – Type: volume Value: 118 – Type: issue Value: 7 Titles: – TitleFull: Addiction (Abingdon, England) Type: main |
| ResultId | 1 |
